Enfuvirtide [`Fuzeon'] and aripiprazole [`Abilify'] have been added to the Special Pharmaceutical Benefits Program

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 424, 2003 , pp. 11-11(1)

Keywords: Aripiprazole, therapeutic use; Enfuvirtide, therapeutic use; Healthcare-news; HIV-infections, treatment; Schizophrenia, treatment

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/peon/2003/00000001/00000424/art00028
http://openurl.ingenta.com/content?genre=article&issn=1173-5503&volume=1&issue=424&spage=11&epage=11
http://dx.doi.org/NO_DOI